Flexible Automation in Drug Discovery
Author Information
Author(s): Derek J. Hook, David M. Evans, Mark Deiparine, Joseph Russo, Christopher Drabik
Primary Institution: Psychiatric Genomics, Inc.
Hypothesis
Can flexible automation improve drug discovery processes?
Conclusion
The study suggests that a multiparametric approach to drug discovery may yield more effective and novel therapies for psychiatric diseases.
Supporting Evidence
- The automation approach allows for high-throughput screening of complex diseases.
- Using gene expression assays can provide insights into the effectiveness of compounds.
- The study emphasizes the need for a systems biology approach in drug discovery.
Takeaway
This study shows that using flexible automation can help find new medicines faster and better, especially for complex diseases like mental illness.
Methodology
The study utilized a Multi-Parameter High Throughput Screen (MPHTSSM) to measure gene expression levels in response to test compounds.
Limitations
The complexity of the assay and the high cost per assay plate may limit its widespread application.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website